Pancreatic cancer halted by virus injection in three patients
- ID
- 48507
- Status
- summarized
- Published
- 20 Nov 2026, 1:25 AM
- Fetched
- 20 Nov 2026, 6:32 AM
- Provider
- Hacker News
- Category
- dev-community
- Original URL
- https://www.newscientist.com/article/2528235-pancreatic-cancer-halted-by-virus-injection-in-three-patients/
- Source URL
- https://hnrss.org/best
Summary
- Score
- 2.0
- Created
- 20 Nov 2026, 6:33 AM
- Tags
- Audience
- developers
What happened
A cancer-killing virus injection stopped pancreatic tumours from growing in three patients in a US safety trial, with the first patient treated a year ago and all three still alive with clinically stable disease. The tumours were confined to the pancreas at treatment time — one was 7 centimetres across — and patients received only one-tenth of the intended dose, according to Masato Yamamoto at the University of Minnesota, who presented the results at the American Society of Gene and Cell Therapy meeting in Boston. Another 15 patients will now get higher doses to find the optimum level, and surgeon Kai Brown at Royal North Shore Hospital in Sydney cautioned that oncology is full of early signals that vanished in phase III testing.
Why it matters
Nothing here changes what a developer, founder, or AI builder ships this week — this is a phase I safety signal with n=3, reported at a conference, not a peer-reviewed efficacy result. The only concrete takeaway is calibration: 'halted' here means stable disease (no growth), not shrinkage, at 10% of the target dose, with 15 more patients still to be dosed. Treat the 304-point HN thread as interest in the topic, not evidence the result is practice-changing.
Discussion angle
Use it as a 2-minute media-literacy exercise: what's the difference between 'tumour halted', 'stable disease', and 'tumour shrunk', and why does dose-escalation with 15 more patients matter before anyone calls this a breakthrough?